[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Central Retinal Vein Occlusion Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 57 pages | ID: C6247D31CBBEN
VPAResearch

US$ 630.00 US$ 700.00 -10 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Central Retinal Vein Occlusion ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Central Retinal Vein Occlusion disease clinical trials. The research work analyzes the ongoing Central Retinal Vein Occlusion clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Central Retinal Vein Occlusion treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Central Retinal Vein Occlusion clinical trials.

Scope of the Report-
  • Ongoing Central Retinal Vein Occlusion clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Central Retinal Vein Occlusion
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Central Retinal Vein Occlusion clinical trials
Reasons to Buy
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Central Retinal Vein Occlusion Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Central Retinal Vein Occlusion Trials by Phase
3.2 Ongoing Central Retinal Vein Occlusion Trials by Type
3.3 Ongoing Central Retinal Vein Occlusion Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Central Retinal Vein Occlusion Trials
4.2 Top 10 Countries conducting Central Retinal Vein Occlusion Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Central Retinal Vein Occlusion Trials by Sponsor Type
5.2 Central Retinal Vein Occlusion Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Central Retinal Vein Occlusion Trials by year
6.2 Subjects Recruited for Central Retinal Vein Occlusion Trials by Phase
6.3 Subjects Recruited for Central Retinal Vein Occlusion Trials by Trial Type
6.4 Subjects Recruited for Central Retinal Vein Occlusion Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Central Retinal Vein Occlusion Trials- Phase
7.2 Ongoing Central Retinal Vein Occlusion Trials- Phase
7.3 Ongoing Central Retinal Vein Occlusion Trials- Phase
7.4 Ongoing Central Retinal Vein Occlusion Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

LIST OF FIGURES

Figure 1: Central Retinal Vein Occlusion- Clinical Trials by Country
Figure 2: Central Retinal Vein Occlusion- Clinical Trials by Phase of Development, 2018
Figure 3: Central Retinal Vein Occlusion- Clinical Trials by Status, 2018
Figure 4: Central Retinal Vein Occlusion- Clinical Trials by Type, 2018
Figure 5: Central Retinal Vein Occlusion- Clinical Trials Split by Region, 2000-2018
Figure 6: Central Retinal Vein Occlusion- Clinical Trials by Type of Economy, 2018
Figure 7: Central Retinal Vein Occlusion- Enrolment by Phase, 2018
Figure 8: Central Retinal Vein Occlusion- Enrolment by Trial Type, 2018
Figure 9: Central Retinal Vein Occlusion- Enrolment by Recruitment Status, 2018
Figure 10: Central Retinal Vein Occlusion- Clinical Trials by Sponsor Type, 2018
Figure 11: Central Retinal Vein Occlusion- Enrolment by Type of Sponsors
Figure 12: Central Retinal Vein Occlusion- Enrolment by Leading Sponsors

LIST OF TABLES

Table 1: Central Retinal Vein Occlusion- Clinical Trials by Sponsor Type, 2018
Table 2: Central Retinal Vein Occlusion- Clinical Trials by Economy Type, 2018
Table 3: Central Retinal Vein Occlusion- Clinical Trials by Region, 2018
Table 4: Central Retinal Vein Occlusion- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Central Retinal Vein Occlusion- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Central Retinal Vein Occlusion- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Central Retinal Vein Occlusion- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Central Retinal Vein Occlusion- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Central Retinal Vein Occlusion- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company


More Publications